P1/2, N=2, Terminated, University of Southern California | N=42 --> 2 | Trial completion date: Apr 2024 --> Dec 2022 | Recruiting --> Terminated | Trial primary completion date: Apr 2023 --> Dec 2022; Study drug no longer available
over 1 year ago
Enrollment change • Trial completion date • Trial termination • Trial primary completion date • Combination therapy • Metastases